A randomized controlled clinical trial to evaluate the effectiveness of sikthakadi taila in patients with Eczema (vicharchika)

A randomized controlled clinical trial on the efficacy of sikthakadi taila in vicharchika w.s.r. to eczema - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/105375

Enrollment

Registered

2026-03-05

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. The Patient having clinical signs and symptoms of vicharchika which are mentioned in classical text will be selected for the study. 2. Patient of age group between 18 years to 60 years according to will be selected for the study. 3. Despite of any gender and socioeconomic status patient will be selected for the study. 4. The patient willing for trial

Exclusion criteria

Exclusion criteria: 1. Patient of age group below 18 years and above 60 years will be excluded. 2. Patient on long term steroids and cytotoxic treatment. 3. Patient suffering from any systemic illness like Hypertension, Diabetes mellitus, Human Immunodeficiency Virus, Tuberculosis, CANCER ect. 4. Pregnant and lactating women. 5. Patient having skin disease other than vicharchika.

Design outcomes

Primary

Measure	Time frame
To study the clinical efficacy of Sikthkadi taila in the management of vicharchika Eczema.Timepoint: 30 Days	—

Secondary

Measure	Time frame
1. To study the literature on vicharchika. 2. To study the literature on Sikthakadi taila and Arka taila. 3. To prepare the sikthakadi tila as mentioned in the Sanhita. 4. To do physicochemical analysis of Sikthakadi tail. 5. To study the efficacy of Sikthakadi taila in the management of vicharchika. 6. To compare the efficacy of trial group and control group.Timepoint: 30 Days	—

Countries

India

Contacts

Public ContactDr Ashwini Abhinandan Patil

LRP Ayurvedic Medical College hospital PG Institute and research centre urun islampur

drashwiniapatil@gmail.com9822735373

Outcome results